PrecisePK Pilots Bayesian Dosing Solutions With Shaare Zedek Medical Center in Israel

White PrecisePK Logo
PrecisePk Pharm. D. Team
January 16, 2023

The largest multidisciplinary medical center in Jerusalem partakes in precision dosing across its teaching hospital, research institution, and academic affiliation with PrecisePK’s capabilities

SAN DIEGO, Jan. 16, 2023– Today, PrecisePK announced that they will begin delivering bayesian dosing solutions to Shaare Zedek Medical Center in Israel. PrecisePK is proud to continue the growth of its worldwide presence and welcomes Shaare Zedek Medical Center as an additional international participant in Bayesian therapeutic drug monitoring.

PrecisePK's precision Bayesian dosing platform is powered by clinical research, machine learning, and cloud computing. Practitioners are guided with an easy-to-use and robust dosing regimen to achieve the target faster with fewer blood draws. PrecisePK is cost-effective and cost-beneficial,  with over 30 years of clinical decision support experience, it automates medication dosing calculations, simplifies hospital workflow, and reduces adverse drug events. Through this significant collaboration, PrecisePK and the long-standing Israeli teaching hospital aligns their missions to improve dosing strategies, clinician training, and patient outcomes.

About Shaare Zedek

Hebrew for “Gates of Justice”, Shaare Zedek is the largest multidisciplinary medical center in Jerusalem with 30 departments and 70 outpatient clinics. Since its establishment in 1902, it has expanded its growth from 20 to 1,000 beds, and now serves hundreds of thousands of patients per year. An esteemed teaching hospital and research institution, Shaare Zedek Medical Center also has an academic affiliation with the Faculty of Medicine of the Hebrew University of Jerusalem.

For more information, please visit

About PrecisePK

PrecisePK was originally designed in 1986 by Philip Anderson, PharmD, FASHP, and other UC San Diego pharmacy consultants, and programmed by Anjum Gupta, Ph.D. It was deployed for use at the UC San Diego Medical Center and Rady Children's Hospital in 1987 as TDMS 2000. In 2015, TDMS 2000 was rebranded as PrecisePK, and continuously improved features like advanced AKI analytics and EHR integration were introduced for PrecisePK to become a robust web-based platform that stands today. Current CEO Anjum Gupta, Ph.D., and consultant Philip Anderson, PharmD, FASHP are both appointed as professors at UC San Diego.

For more information, please visit our website at 

Try PrecisePK Precision Dosing Software Free for 60 days

Optimize Your Clinical Experience with PrecisePK.